Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
AssigneeAlbert Einstein College of Medicine of Yeshiva University
InventorsRadhika Muzumdar, David J. Lefer
Life of this patent
Estimating the term…
Abstract
Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
Claims6
1-76. (canceled)
A method of treating or preventing myocardial injury in a subject comprising administering to the subject a humanin analog having the amino acid sequence of SEQ ID NO:4 in an amount effective to treat or prevent myocardial injury in a subject.
80-91. (canceled)
Dependencies are inferred from the claim text.